| Salmonella, the host and disease: a brief review B Coburn, GA Grassl, BB Finlay Immunology and cell biology 85 (2), 112-118, 2007 | 1107 | 2007 |
| Type III secretion systems and disease B Coburn, I Sekirov, BB Finlay Clinical microbiology reviews 20 (4), 535-549, 2007 | 836 | 2007 |
| Intestinal ABCA1 directly contributes to HDL biogenesis in vivo LR Brunham, JK Kruit, J Iqbal, C Fievet, JM Timmins, TD Pape, ... The Journal of clinical investigation 116 (4), 1052-1062, 2006 | 661 | 2006 |
| Does this adult patient with suspected bacteremia require blood cultures? B Coburn, AM Morris, G Tomlinson, AS Detsky Jama 308 (5), 502-511, 2012 | 430 | 2012 |
| Lung microbiota across age and disease stage in cystic fibrosis B Coburn, PW Wang, J Diaz Caballero, ST Clark, V Brahma, S Donaldson, ... Scientific reports 5 (1), 10241, 2015 | 405 | 2015 |
| Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, ... The Lancet Respiratory Medicine 9 (5), 522-532, 2021 | 279 | 2021 |
| Salmonella enterica Serovar Typhimurium Pathogenicity Island 2 Is Necessary for Complete Virulence in a Mouse Model of Infectious Enterocolitis B Coburn, Y Li, D Owen, BA Vallance, BB Finlay Infection and immunity 73 (6), 3219-3227, 2005 | 267 | 2005 |
| Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma M Oliva, A Spreafico, M Taberna, L Alemany, B Coburn, R Mesia, LL Siu Annals of oncology 30 (1), 57-67, 2019 | 236 | 2019 |
| Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial JJ Feld, C Kandel, MJ Biondi, RA Kozak, MA Zahoor, C Lemieux, ... The Lancet Respiratory Medicine 9 (5), 498-510, 2021 | 230 | 2021 |
| Analysis of the Contribution of Salmonella Pathogenicity Islands 1 and 2 to Enteric Disease Progression Using a Novel Bovine Ileal Loop Model and a Murine … BK Coombes, BA Coburn, AA Potter, S Gomis, K Mirakhur, Y Li, BB Finlay Infection and immunity 73 (11), 7161-7169, 2005 | 210 | 2005 |
| Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label … SS Hota, V Sales, G Tomlinson, MJ Salpeter, A McGeer, B Coburn, ... Clinical Infectious Diseases 64 (3), 265-271, 2017 | 208 | 2017 |
| Gut-associated IgA+ immune cells regulate obesity-related insulin resistance H Luck, S Khan, JH Kim, JK Copeland, XS Revelo, S Tsai, M Chakraborty, ... Nature communications 10 (1), 3650, 2019 | 189 | 2019 |
| Salmonella Pathogenicity Island 2 Is Expressed Prior to Penetrating the Intestine NF Brown, BA Vallance, BK Coombes, Y Valdez, BA Coburn, BB Finlay PLoS pathogens 1 (3), e32, 2005 | 172 | 2005 |
| Selective sweeps and parallel pathoadaptation drive Pseudomonas aeruginosa evolution in the cystic fibrosis lung J Diaz Caballero, ST Clark, B Coburn, Y Zhang, PW Wang, SL Donaldson, ... MBio 6 (5), 10.1128/mbio. 00981-15, 2015 | 147 | 2015 |
| The Salmonella enterica Serovar Typhimurium Divalent Cation Transport Systems MntH and SitABCD Are Essential for Virulence in an Nramp1G169 Murine … ML Zaharik, VL Cullen, AM Fung, SJ Libby, SL Kujat Choy, B Coburn, ... Infection and immunity 72 (9), 5522-5525, 2004 | 147 | 2004 |
| The microbiome and cancer for clinicians SL Picardo, B Coburn, AR Hansen Critical reviews in oncology/hematology 141, 1-12, 2019 | 145 | 2019 |
| Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection ME Wickham, C Lupp, M Mascarenhas, A Vázquez, BK Coombes, ... The Journal of infectious diseases 194 (6), 819-827, 2006 | 141 | 2006 |
| Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis ST Clark, J Diaz Caballero, M Cheang, B Coburn, PW Wang, ... Scientific reports 5 (1), 10932, 2015 | 119 | 2015 |
| Salmonella enterica Serovar Senftenberg Human Clinical Isolates Lacking SPI-1 Q Hu, B Coburn, W Deng, Y Li, X Shi, Q Lan, B Wang, BK Coombes, ... Journal of Clinical Microbiology 46 (4), 1330-1336, 2008 | 109 | 2008 |
| Nramp1 drives an accelerated inflammatory response during Salmonella‐induced colitis in mice Y Valdez, GA Grassl, JA Guttman, B Coburn, P Gros, BA Vallance, ... Cellular microbiology 11 (2), 351-362, 2009 | 91 | 2009 |
